DOI: 10.1055/s-00000072

Seminars in Reproductive Medicine

Ausgabe 03 · Volume 28 · Mai 2010 DOI: 10.1055/s-002-20980 Insights and Advances in Uterine Leiomyomas William H Catherino M.D. Ph.D.

INTRODUCTION TO GUEST EDITOR

  • 165
    Carr, Bruce R:

    William H. Catherino, M.D., Ph.D.

    • PREFACE

  • 167
    Catherino, William H:

    Insights and Advances in Uterine Leiomyomas

  • 169
    Malik, Minnie; Norian, John; McCarthy-Keith, Desirée; Britten, Joy; Catherino, William H:

    Why Leiomyomas Are Called Fibroids: The Central Role of Extracellular Matrix in Symptomatic Women

  • 180
    Chegini, Nasser:

    Proinflammatory and Profibrotic Mediators: Principal Effectors of Leiomyoma Development as a Fibrotic Disorder

  • 204
    Laughlin, Shannon K; Schroeder, Jane C; Baird, Donna Day:

    New Directions in the Epidemiology of Uterine Fibroids

  • 218
    Olive, David L; Pritts, Elizabeth A:

    Fibroids and Reproduction

  • 228
    Agdi, Mohammed; Tulandi, Togas:

    Minimally Invasive Approach for Myomectomy

  • 235
    Freed, Max M; Spies, James B:

    Uterine Artery Embolization for Fibroids: A Review of Current Outcomes

  • 242
    Al Hilli, Mariam M; Stewart, Elizabeth A:

    Magnetic Resonance-Guided Focused Ultrasound Surgery

  • 250
    Yu, Linda; Moore, Alicia B; Dixon, Darlene:

    Receptor Tyrosine Kinases and Their Hormonal Regulation in Uterine Leiomyoma

  • 260
    Yoshida, Shigeki; Ohara, Noriyuki; Xu, Qin; Chen, Wei; Wang, Jiayin; Nakabayashi, Koji; Sasaki, Hiroko; Morikawa, Akira; Maruo, Takeshi:

    Cell-Type Specific Actions of Progesterone Receptor Modulators in the Regulation of Uterine Leiomyoma Growth